Seline E. Miller - 13 Oct 2021 Form 3 Insider Report for CATALYST BIOSCIENCES, INC. (GYRE)

Role
SVP Finance; Interim CFO & PAO
Signature
/s/ Seline Miller
Issuer symbol
GYRE
Transactions as of
13 Oct 2021
Net transactions value
$0
Form type
3
Filing time
21 Oct 2021, 16:50:51 UTC
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CBIO Stock Option (Right to Buy) 13 Oct 2021 Common Stock 16,000 $4.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on the one-year anniversary of the vesting commencement date of April 15, 2021, and 1/48 of the shares subject to the option will vest on each monthly anniversary of the vesting commencement date thereafter.